Back

Discussion - Risk Scores: Advantages and Pitfalls

10 November 2019 (09:15 - 09:20)
Organised by:
Congress Presentation Part of: How to Assess Cardiovascular Risk in Clinical Practice? Cardiovascular Risk Assessment ESC Premium Access ESC Asia with APSC & AFC

5 More presentations in this session

Presentation thumbnail
Risk Scores: Advantages and Pitfalls.
Professor S. Gielen (Detmold, DE)
Slides Video
Presentation thumbnail
Biomarkers in Risk Assessment: Lipids and Beyond.
Doctor A. Fong (Kuching, MY)
Slides Video
Presentation thumbnail
Discussion - Biomarkers in Risk Assessment: Lipids and Beyond.
Presentation thumbnail
Imaging – A Must or an Add-on in Risk Assessment?
Professor M. Marwan (Erlangen, DE)
Slides Video
Presentation thumbnail
Discussion - Imaging – A Must or an Add-on in Risk Assessment?

Access the full session

Session thumbnail
How to Assess Cardiovascular Risk in Clinical Practice?

The Event

Event poster

ESC Asia with APSC & AFC

10 November 2019 09:15 CET
You may be interested in
thumbnail
Webinar
ACVC Biomarker Talk Series - Screening the general population - a role for cardiac biomarkers?
13 July 2022
thumbnail
Congress Presentation
Reassessing surgical risk models in infective endocarditis: are they still valid beyond surgery?
21 March 2026
thumbnail
Congress Presentation
Prediction models and scores in pulmonary hypertension
1 September 2025
thumbnail
Congress Presentation
Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources